Skip to main content
Top

Drugs

Issue 5/2022

Content (10 Articles)

Pharmacotherapeutic Treatment of Glioblastoma: Where Are We to Date?

Lidia Gatto, Vincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, Stefania Bartolini, Alba Ariela Brandes

From a Symptom-Based to a Mechanism-Based Pharmacotherapeutic Treatment in Complex Regional Pain Syndrome

Thomas J. P. Mangnus, Krishna D. Bharwani, Maaike Dirckx, Frank J. P. M. Huygen

Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria

George G. Zhanel, Marianna Pozdirca, Alyssa R. Golden, Courtney K. Lawrence, Sheryl Zelenitsky, Liam Berry, Frank Schweizer, Denice Bay, Heather Adam, Michael A. Zhanel, Philippe Lagacé-Wiens, Andrew Walkty, Neal Irfan, Kurt Naber, Joseph P. Lynch III, James A. Karlowsky

Contemporary Management of Dyslipidemia

Richard A. Ferraro, Thorsten Leucker, Seth S. Martin, Maciej Banach, Steven R. Jones, Peter P. Toth

Aumolertinib: A Review in Non-Small Cell Lung Cancer

  • NSCLC
  • Adis Drug Evaluation

Matt Shirley, Susan J. Keam

Nirmatrelvir Plus Ritonavir: First Approval

Yvette N. Lamb

Sugemalimab: First Approval

Sohita Dhillon, Sean Duggan

Daridorexant: First Approval

Anthony Markham

Correction to: Abrocitinib: First Approval

  • Open Access
  • Correction

Emma D. Deeks, Sean Duggan

Correction to: Efgartigimod: First Approval

Young-A Heo

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images